FDA regulations make medical innovation a waiting game

Medical research is not a field for people who like instant gratification. There are long waits as cultures grow, proteins crystallize and cells divide. And when a discovery finally becomes something tangible, like a medication, it can still take years of testing and government approvals before a patient can benefit from it.

But what happens when a life is at stake and time is a luxury the patient simply cannot afford?

That is the question asked by NBC News’ Rock Center in a recent piece they did on Boston Children’s Hospital surgeon, Mark Puder, MD, PhD. Puder has help develop a potentially life saving drug called Omegaven, which he’s been using to help reverse fatal liver disease in infants. However, despite the drug’s effectiveness in Puder’s patients, the Food and Drug Administration has yet to approve its use nationwide.

Visit NBCNews.com for breaking news, world news, and news about the economy